Ads
related to: metastatic colorectal cancer treatment- Newly Diagnosed Data
Explore Data In Newly Diagnosed
Patients With WT RAS* mCRC.
- Biomarker Testing
See The Importance Of Biomarker
Identification For Your Patients.
- Dosing & Administration
Learn About Dosing Modifications &
Review Administration Information.
- Clinical Data & Studies
View Study Design, Safety Profile,
And Primary & Secondary Endpoints.
- Hypothetical Profiles
Find Clinical Characteristics That
Affect Your Treatment Decision.
- Chemorefractory Data
Review Studies In Patients With
Chemorefractory WT RAS* mCRC.
- Newly Diagnosed Data
Search results
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 9 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive new results from an ongoing Phase 1/2 trial evaluating its first-in-class costimulatory bispecific antibody, REGN7075 ...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 1 day agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Oncologists should 'revisit' end-of-life care goals: Yale, MD Anderson study
Becker’s Hospital Review· 2 days agoAdministering more treatments to advanced, end-of-life cancer patients did not increase their length of survival, according to a joint study from researchers ...
MD Anderson Research Highlights: ASCO 2024 Special | Newswise
Newswise· 1 day agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
NCCN Publishes New Resource for Patients with Inte | Newswise
Newswise· 4 days agoThis free resource for people facing cancer and caregivers is focused on a rare cancer type that...
Dr. Reddy's (RDY), Alvotech Unite for Prolia & Xgeva Biosimilar
Zacks via Yahoo Finance· 2 days agoDr. Reddy's (RDY) announces entering into a license and supply agreement with Alvotech to develop...
Gene Panel Predicts Early HER2+ Breast Cancer Prognosis
Medscape· 4 days agoPatients with early-stage HER2+ breast cancer could soon be offered less intensive treatment based...
Get Ready for ASCO 2024 Annual Meeting | Newswise
Newswise· 2 days agoASCO, the largest event in cancer research, is approaching on May 31st. This year's meeting promises to be particularly groundbreaking, with new findings a
ASCO: With hopes high, Regeneron misses mark with just 1 complete response in solid tumor trial so...
FierceBiotech· 10 hours agoRegeneron’s costimulatory bispecific antibody REGN7075 is being tested in patients with advanced...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 9 hours agoHOOKIPA to present an oral abstract at the American Society for Clinical Oncology (ASCO) 2024 Annual Meeting on June 4Updated data of HB-200 plus pembrolizumab demonstrate a favorable safety profile and promising clinical activity In a subset
Ad
related to: metastatic colorectal cancer treatment
